Global surveillance, national surveillance, and SARS.
During the last decade of the 20th century, several outbreaks, including cholera in Latin America, pneumonic plague in India, and Ebola hemorrhagic fever in the Democratic Republic of the Congo, caused great international concern (1-3). These events demonstrated the consequences that delayed national recognition and response to outbreaks could have: illness and death of national populations including health workers, potential spread to other countries, and significant disruptions of travel and trade. These outbreaks also emphasized the need for a global surveillance and response mechanism. The Global Outbreak Alert and Response Network (GOARN), set up in 1997 and formalized in 2000, was one major response to this need (World Health Organization [WHO], unpub, data and 4). Though the network, which now has over 120 partners throughout the world, currently identifies and responds to more than 50 outbreaks in developing comltries each year, the SARS outbreak was the first time that GOARN identified and responded to an outbreak that was rapidly spreading internationally.
One of the partners in GOARN is the WHO Global Influenza Surveillance Network, which was established in 1947 to guide the annual composition of vaccines and provide an early alert to variants that might signal the start of a pandemic of rapidly evolving influenza viruses. This network was placed on alert in late November, when the Canadian Global Public Health Intelligence Network (GPHIN), also a partner in GOARN, picked up media reports of an influenza outbreak in mainland China (5). Simultaneously, another GOARN partner, the U.S. Global Emerging Infections Surveillance and Response System (GEIS), became aware of similar reports about a severe outbreak, with influenza B the suspected cause, in Beijing and Guangzhou. As GOARN continued to receive reports about influenza outbreaks in China, WHO requested information from Chinese authorities on December 5 and 11. On December 12, WHO received a detailed report on data collected at Chinese influenza surveillance sites, indicating that investigation of 23 influenza virus isolates had confirmed type B strains in all but one and that the number of cases was consistent with the seasonal pattern in previous years. The information was reassuring and an indication that the influenza surveillance system was working well.
Although information is incomplete, retrospective case identification by Chinese and GOARN epidemiologists since May 2003 suggests that two respiratory disease outbreaks occurred in Guangdong Province in late November 2002: influenza and what now appears to have been a first wave of SARS cases--an atypical pneumonia that was characterized by small, seemingly unrelated clusters of cases scattered over several municipalities in Guangdong, with low-level transmission to healthcare workers (6). This first wave of atypical pneumonia appears to have continued until a second wave of disease with amplified transmission to health workers began occurring during the first 10 days of February (WHO, unpub, data). On February 10, 2003, the WHO office in Beijing received an email message describing an infectious disease in Guangdong Province said to have caused more than 100 deaths. On February 11, the Guangzhou Bureau of Health reported to the press more than 100 cases of a respiratory atypical pneumonia outbreak that had been spreading in the city for more than 1 month. That same day, the Chinese Ministry of Health in Beijing officially reported to WHO 300 cases and 5 deaths in an outbreak of acute respiratory syndrome, and the next day reported that the outbreak dated back to November 16, 2002, that influenza virus had not yet been isolated, and that the outbreak was coming under control (7).
When the reports of a severe respiratory disease were received by WHO on February 11, 2003, a new strain of influenza virus was the most feared potential cause, and the WHO Global Influenza Network was again alerted. Concern grew on February 20, when the network received reports from Hong Kong authorities confirming the detection of A(H5N1) avian influenza virus in two persons, and WHO activated its influenza pandemic preparedness plans (8).
During that same week, laboratories of the WHO Global Influenza Surveillance Network began analyzing specimens from a patient with severe atypical pneumonia hospitalized in Hanoi after travel to Hong Kong. Concurrently, GOARN response teams in Vietnam and Hong Kong began collecting clinical and epidemiologic information about the patient and a growing number of others with similar symptoms. As more specimens entered the network laboratories, influenza viruses were ruled out as the causative agent. WHO made its first global alert on March 12, followed by a second, on March 15, when more than 150 suspected new cases had been reported from several geographic areas, including Hong Kong, Singapore, Vietnam and Canada (9,10). With the second alert, WHO provided a case definition and name, thus beginning a coordinated global outbreak response that brought heightened vigilance everywhere and intense control efforts. GOARN linked some of the world's best laboratory scientists, clinicians, and epidemiologists electronically, in virtual networks that provided rapid knowledge about the causative agent, mode of transmission, and other epidemiologic features (11). This real-time information made it possible for WHO to provide specific guidance to health workers on clinical management and protective measures to prevent further nosocomial spread. It also made possible recommendations to international travelers to curtail international spread. Recommendations were at first nonspecific, urging international travelers to have a high level of suspicion if they had traveled to or from areas where the outbreak was occurring. But as more information became available, airports were asked to screen passengers for history of contact with SARS and for persons with current illness that fit the SARS case definition. Finally, when these recommendations did not completely stop international spread, passengers themselves were asked to avoid travel to areas where contact tracing was unable to link all cases to known chains of transmission (12). Within 4 months, transmission of SARS had been interrupted at all sites, and on July 5, 2003, the SARS outbreak was declared contained (13).
As many times occurs with emerging and reemerging infectious diseases, national surveillance mechanisms failed to identify and respond to the emerging outbreak of SARS early enough to prevent its toll of sickness, death, and international spread (14). In May 2003, ministers of health from the 192 member countries of WHO expressed their deep concern about the impact of SARS and its implications for future outbreaks, which were considered inevitable. In two resolutions, they called for increased national capacity development for surveillance and response and endorsed the ways in which GOARN obtained information about SARS and supported containment efforts (15,16). The resolutions stressed the need for countries to give more attention, with WHO support, to the strengthening of national surveillance and response capacity, and encouraged WHO to continue to strengthen GOARN, its safety net for global alert and response. As SARS so amply demonstrated, protection against the threat of emerging and epidemic-prone diseases requires strong defense systems at national as well as international levels.
(1.) Tauxe RV, Mintz ED, Quick RE. Epidemic cholera in the New World: translating field epidemiology into new prevention strategies. Emerg Infect Dis 1995;1:141-6.
(2.) Plague--international team of experts, India. Wkly Epidemiol Rec 1994;69:321-2.
(3.) Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiens B, et al. The re-emergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(suppl1):S76-86.
(4.) Heymann DL, Rodier GR, WHO Operational Support Team to the Global Outbreak Alert and Response Network, Hot spots in a wired world: WHO surveillance of emerging and re-emerging infbctious diseases. Lancet Infect Dis 2001;1:345-53.
(5.) SARS--Chronology of events. Ottawa: Health Canada, Population and Public Health Branch; 2003.
(6.) Zhong NS, Zheng BJ, Li YM, Pooh LLM, Xie ZH, Chan KH, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003;362:1353-58.
(7.) Acute respiratory syndrome, China. Wkly Epidemiol Rec 2003;78:41.
(8.) Influenza A (H5N1), Hong Kong Special Administrative Region of China. Wkly Epidemiol Rec 2003;78:49-50.
(9.) WHO issues a global alert about cases of atypical pneumonia. [cited December 15, 2003]. Available from: URL: http://www.wbo.int/csr/ sars/archive/2003_03_12/en/
(10.) World Health Organization issues emergency travel advisory, [cited December 15, 2003]. Available from: URL: http://www.who.int/csr/ sars/archive/2003_03_15/en/
(11.) World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome (SARS) Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3.
(12.) Severe acute respiratory syndrome, update 92-chronology of travel recommendations, areas with local transmission. [cited December 15, 2003]. Available from: URL: http://www.who.int/csr/don/2003_ 07_01/en/
(13.) Severe acute respiratory syndrome, update 96-Taiwan, China: SARS transmission interrupted in last outbreak area. [cited December 15, 2003]. Available from: URL: http://www.who.int/csr/don/2003_ 07_01/en/
(14.) Breiman RF, Evans MR, Preiser W, Maguire J, Schnur A, Li A, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1037-41.
(15.) World Health Organization. Severe acute respiratory syndrome. Geneva: World Health Organization; 2003 (World Health Assembly resolution WHA56.29. [cited December 15, 2003]. Available from: URL: http://www.who.int/gb/EB_WHA/PDF/WHA56/ea56r29.pdf
(16.) World Health Organization. Revision of the international health regulations. Geneva: World Health Organization, 2003 (World Health Assembly resolution WHA56.28), [cited December 15, 2003]. Available from: URL: http://www.who.int/gb/EB_WHA/PDF/ WHA56/ea56r28.pdf
Address for correspondence: David L. Heymann, World Health Organization, Avenue Appia 20, CH-1211 Geneve 27, Switzerland; fax: 41 22 791 2212; email: firstname.lastname@example.org
Dr. Heymann is a medical epidemiologist who began his career in India with the smallpox eradication program. After completing the Epidemic Intelligence Service, Dr. Heymann spent 13 years working for CDC in sub-Saharan Africa in infectious diseases that range from Ebola, yaws, and yellow fever to the routine childhood immunizable diseases and malaria. On joining the World Health Organization, Dr. Heymann worked with the AIDS program then set up and directed the Department of Emerging and other Infectious Diseases before becoming executive director for the Communicable Disease program, followed by his present assignment as the representative of the director general, heading the Polio Eradication Initiative.
Dr. Rodier is currently the director, Department of Communicable Disease Surveillance and Response, World Health Organization. His main professional experience includes the development of new approaches for communicable disease surveillance and response at national and global levels, and comprehensive field experience in epidemic response, particularly in viral hemorrhagic fever.
David L. Heymann * and Guenael Rodier *
* World Health Organization, Geneva, Switzerland
|Printer friendly Cite/link Email Feedback|
|Publication:||Emerging Infectious Diseases|
|Date:||Feb 1, 2004|
|Previous Article:||The impressive and rapidly expanding knowledge base on SARS.|
|Next Article:||SARS-related virus predating SARS outbreak, Hong Kong.|